Key result
Metabolic and molecular imaging tools, such as PET and MRI, permit the detection and quantification of myocardial metabolic remodeling in diabetic cardiomyopathy.
Why the study?
Advances in metabolic and molecular imaging allow quantification of myocardial metabolic remodeling in diabetic cardiomyopathy, but their mechanistic, therapeutic, and clinical applications needed review.
Design
Review
Authors
Loading...
May aid research on diabetic cardiomyopathy; leaves open effects on management or outcomes.
Advanced imaging modalities like PET and MRI are essential for detecting and quantifying metabolic remodeling in diabetic cardiomyopathy, aiding in both clinical management and the development of novel metabolic therapies.
Peterson et al. (2020) conducted a review in Diabetic cardiomyopathy. Metabolic and molecular imaging (PET, MRI, MRS) was evaluated. Metabolic and molecular imaging tools, such as PET and MRI, permit the detection and quantification of myocardial metabolic remodeling in diabetic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: